A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 3 I, 2000, Pages 996-1001

  Kips, Johan C ^a   O'Connor, Brian J ^b   Inman, Mark D ^b   Svensson, Klas ^b   Pauwels, Romain A ^b   O'Byrne, Paul M ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FORMOTEROL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

EID: 0034105388     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.3.9812056     Document Type: Article

References (34)

1. National Institutes of Health, National Heart, Lung, and Blood Institute. 1995. Global Initiative for Asthma. U.S. Government Printing Office, Washington, DC. Publication No. 95-3659.
2. British Thoracic Society. 1997. The British guidelines on asthma management 1995 review and position statement. Thorax 52:s1-s21.
3. Greening, A. P., P. W. Ind, M. Northfield, and G. Shaw. 1994. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:219-224.
4. Woolcock, A., B. Lundback, N. Ringdal, and L. A. Jacques. 1996. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 153:1481-1488.
5. Pauwels, R. A., C. G. Löfdahl, D. S. Postma, A. E. Tattersfield, P. M. O'Byrne, P. J. Barnes, and A. Ullman. 1997. Effect of inhaled formoterol and budesonide on asthma exacerbations. N. Engl. J. Med. 337:1405-1411.
6. 2-agonists in asthma treatment. In R. Pauwels and P. M. O'Byrne, editors. Lung Biology in Health and Disease. Marcel Dekker, New York. 67-86.
7. Gardiner, P. V., C. Ward, H. Booth, A. Allison, D. J. Hendrick, and E. H. Walters. 1994. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am. J. Respir. Crit. Care Med. 150:1006-1011.
8. Wallin, A., T. Sandström, M. Söderberg, P. Howarth, B. Lundbäck, G. Della-Cioppa, S. Wilson, M. Judd, R. Djukanovic, S. Holgate, A. Lindberg, and L. Larssen. 1999. The effects of regular inhaled formoterol, budesonide on mucosal inflammation and clinical indices in mild asthma. Am. J. Respir. Crit. Care Med. 158:79-86.
9. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiades, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
10. McIvor, R. A., E. Pizzichini, M. O. Turner, P. Hussack, F. E. Hargreave, and M. R. Sears. 1998. Potential masking effects of salmeterol on airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 158:924-930.
11. Sont, J. K., J. H. J. M. van Krieken, C. E. Evertse, R. Hooijer, L. N. A. Willems, and P. J. Sterk. 1996. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
12. Pin, I., P. G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. A. Denburg, F. E. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:25-29.
13. Bentley, A. M., G. Menz, C. Storz, D. S. Robinson, B. Bradley, P. K. Jeffery, S. R. Durham, and A. B. Kay. 1992. Identification of T lymphocytes, macrophages and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am. Rev. Respir. Dis. 146:500-506.
14. Djukanovic, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142:863-871.
15. Kips, J. C., J. Fahy, F. E. Hargreave, P. Ind, and J. in't Veen. 1998. Position paper on methods for sputum induction and analysis of induced sputum as a method for assessing airway inflammation in asthma. Eur. Respir. J. 11:9s-12s.
16. O'Byrne, P. M., and M. D. Inman. 1996. Induced sputum to assess airway inflammation in asthma. Eur. Respir. J. 9:2345-2346.
17. Pavord, I. D., M. M. M. Pizzichini, E. Pizzichini, and F. E. Hargreave. 1997. The use of induced sputum to investigate airway inflammation. Thorax 52:498-501.
18. Corrigan, C. J., and A. B. Kay. 1995. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-507.
19. Fahy, J. V., J. Liu, H. Wong, and H. A. Boushey. 1993. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. 147:1126-1131.
20. In 't Veen, J. C. C. M., H. W. F. M. de Gouw, H. H. Smits, J. K. Sont, P. S. Hiemstra, P. J. Sterk, and E. H. Bel. 1996. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur. Respir. J. 9:2441-2447.
21. Keatings, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
22. Maestrelli, P., M. Saetta, A. Di Stefano, P. C. Calcagni, G. Turato, M. P. Ruggieri, A. Roggeri, C. E. Mapp, and L. M. Fabbri. 1995. Comparison of leucocyte counts in sputum, bronchial biopsies and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 152:1926-1931.
23. Keatings, V. M., D. J. Evans, B. J. O'Connor, and P. J. Barnes. 1997. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 52: 372-374.
24. Grootendorst, D. C., J. K. Sont, L. N. A. Willems, J. C. Kluin-Nelemans, J. H. J. M. van Krieken, M. Veselic Charvat, and P. J. Sterk. 1997. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin. Exp. Allergy 27:769-779.
25. Fahy, J. V., H, Wong, J. Liu, and H. A. Boushey. 1995. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am. J. Respir. Crit. Care Med. 152:53-58.
26. Claman, D. M., H. A. Boushey, J. Liu, H. Wong, and J. V. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
27. Wong, B. J., J. Dolovich, E. H. Ramsdale, P. O'Byrne, L. Gontovnick, J, A. Denburg, and F. E. Hargreave. 1992. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 146:1156-1160.
28. Jatakanon, A., S. Kharitonov, S. Lim, and P. J. Barnes. 1999. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54:108-114.
29. Jahnsen, F. L., P. Brandtzeag, and T. S. Halstensen. 1994. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J. Immunol. Methods 175:23-36.
30. Moqbel, R., J. Barkans, B. L. Bradley, S. R. Durham, and A. B. Kay. 1992. Application of monoclonal antibodies against major basic protein (BMK-13) and eoisinophilic cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin. Exp. Allergy 22:265-273.
31. Nasser, S. M. S., R. Pfister, P. E. Christie, A. R. Sousa, J. Barker, M. Schmitz-Schumann, and T. H. Lee. 1996. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am. J. Respir. Crit. Care Med. 153:90-96.
32. Sullivan, P., D. Stephens, T. Ansari, J. Costello, and P. Jeffery. 1998. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur. Respir. J. 12:811-815.
33. Sur, S., D. G. Glitz, H. Kita, S. M. Kujawa, E. A. Peterson, D. A. Weiler, G. M. Kephart, J. M. Wagner, T. J. George, G. J. Gleich, and K. M. Leiferman. 1998. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leucocytes. J. Leukocyte Biol. 63:715-722.
34. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiades, J. Dolovich, and F. E. Hargreave. 1997. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J. Allergy Clin. Immunol. 99:539-544.